SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

XORTX Therapeutics Inc. (XRTX) News

Follow XORTX Therapeutics Inc. (XRTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol XRTX Asset equity Sector Markets 90 days 5 Last 1.1 Updated Sep 18, 2026, 12:11 PM UTC Open live news feed Open XRTX chart & news
L XRTX - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity XRTX - XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity REGULATION | Sep 18, 2026, 12:11 PM UTC L XORTX Therapeutics starts drug and tablet manufacturing for XRx-026 XORTX Therapeutics Inc said it has initiated drug and tablet manufacturing for its XRx-026 program. EQUITY | Sep 10, 2026, 08:13 PM UTC L XORTX initiates clinical and commercial manufacturing of XORLO™ ● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ●CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) -- XORTX Thera EQUITY | Sep 10, 2026, 08:11 PM UTC L XORTX Announces Termination and Postponement of Investor Relations Program XORTX Announces Termination and Postponement of Investor Relations Program EQUITY | Aug 28, 2026, 11:07 AM UTC L XRTX terminates and postpones investor relations program XRTX/XORTX said it is terminating and postponing its investor relations program. EQUITY | Aug 28, 2026, 11:00 AM UTC L XORTX Director Resigns XORTX director resigns EQUITY | Jul 31, 2026, 09:00 PM UTC L XRTX - XORTX Appoints New Director XRTX - XORTX Appoints New Director EQUITY | Jul 29, 2026, 11:01 AM UTC L 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by EQUITY | Jun 30, 2026, 12:05 PM UTC